Judge Says Impax, Apotex Infringed Prilosec Patents

Law360, New York (June 4, 2007, 12:00 AM EDT) -- Almost a year after the trial concluded in the long-standing dispute over AstraZeneca AB’s patents for its gastric acid-inhibiting drug Prilosec, a federal judge ruled Thursday that the patents were valid and that Apotex Corp. and Impax Laboratories Inc. had both infringed with their generic versions of the drug.

Judge Barbara Jones of the U.S. District Court for the Southern District of New York also found that the other defendants in the case, Mylan Laboratories Inc., Laboratorios Dr. Esteve SA (LDE), and Lek Pharmaceutical and Chemical...
To view the full article, register now.